Heidi Irma Louisa Jacobs, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Locus Coeruleus | 14 | 2022 | 148 | 5.800 |
Why?
|
Alzheimer Disease | 57 | 2022 | 7165 | 5.690 |
Why?
|
Amyloid beta-Peptides | 35 | 2022 | 3167 | 2.520 |
Why?
|
tau Proteins | 25 | 2022 | 1623 | 2.260 |
Why?
|
Memory | 11 | 2022 | 2154 | 2.000 |
Why?
|
Norepinephrine | 5 | 2022 | 912 | 1.850 |
Why?
|
Parietal Lobe | 8 | 2018 | 818 | 1.600 |
Why?
|
Parahippocampal Gyrus | 4 | 2020 | 121 | 1.470 |
Why?
|
Hippocampus | 11 | 2021 | 3639 | 1.170 |
Why?
|
Brain | 33 | 2022 | 24969 | 1.130 |
Why?
|
Magnetic Resonance Imaging | 51 | 2022 | 34151 | 1.040 |
Why?
|
Positron-Emission Tomography | 29 | 2022 | 6170 | 0.990 |
Why?
|
Solitary Nucleus | 2 | 2021 | 53 | 0.960 |
Why?
|
Cognition Disorders | 8 | 2018 | 3956 | 0.910 |
Why?
|
Brain Mapping | 17 | 2021 | 6545 | 0.890 |
Why?
|
Longevity | 2 | 2020 | 1019 | 0.860 |
Why?
|
Cerebellum | 2 | 2020 | 1489 | 0.850 |
Why?
|
Salivary alpha-Amylases | 1 | 2021 | 15 | 0.850 |
Why?
|
Cerebral Cortex | 9 | 2021 | 5703 | 0.840 |
Why?
|
CADASIL | 1 | 2021 | 80 | 0.810 |
Why?
|
Apolipoproteins E | 4 | 2022 | 1465 | 0.780 |
Why?
|
Blood-Brain Barrier | 5 | 2019 | 992 | 0.780 |
Why?
|
Saliva | 2 | 2021 | 793 | 0.740 |
Why?
|
Temporal Lobe | 8 | 2021 | 1655 | 0.720 |
Why?
|
Memory Disorders | 4 | 2021 | 1139 | 0.710 |
Why?
|
Leukoencephalopathies | 1 | 2021 | 252 | 0.680 |
Why?
|
Nerve Net | 4 | 2021 | 2138 | 0.670 |
Why?
|
Sympathetic Nervous System | 1 | 2021 | 533 | 0.660 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2022 | 603 | 0.660 |
Why?
|
Cognition | 14 | 2022 | 5982 | 0.650 |
Why?
|
Leukoaraiosis | 1 | 2018 | 137 | 0.630 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2014 | 991 | 0.600 |
Why?
|
Aging | 9 | 2022 | 8358 | 0.590 |
Why?
|
Mental Processes | 3 | 2019 | 251 | 0.580 |
Why?
|
Neuropsychological Tests | 15 | 2021 | 6879 | 0.580 |
Why?
|
Executive Function | 4 | 2021 | 1307 | 0.580 |
Why?
|
Neural Pathways | 7 | 2018 | 3004 | 0.570 |
Why?
|
Aged | 62 | 2022 | 161488 | 0.550 |
Why?
|
Learning | 3 | 2021 | 1596 | 0.520 |
Why?
|
Dementia | 4 | 2019 | 2227 | 0.520 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2015 | 147 | 0.490 |
Why?
|
Tauopathies | 3 | 2021 | 279 | 0.470 |
Why?
|
Vagus Nerve | 1 | 2015 | 444 | 0.450 |
Why?
|
Vagus Nerve Stimulation | 1 | 2015 | 184 | 0.450 |
Why?
|
Disease Progression | 15 | 2021 | 13298 | 0.450 |
Why?
|
Visual Perception | 3 | 2019 | 1401 | 0.430 |
Why?
|
Methoxyhydroxyphenylglycol | 2 | 2021 | 91 | 0.430 |
Why?
|
Humans | 96 | 2022 | 708843 | 0.420 |
Why?
|
Peptide Fragments | 6 | 2022 | 5141 | 0.410 |
Why?
|
Male | 69 | 2022 | 349524 | 0.400 |
Why?
|
Organ Size | 6 | 2021 | 2317 | 0.400 |
Why?
|
Aged, 80 and over | 32 | 2021 | 58184 | 0.390 |
Why?
|
Middle Aged | 45 | 2022 | 213752 | 0.390 |
Why?
|
Image Processing, Computer-Assisted | 10 | 2017 | 8968 | 0.380 |
Why?
|
Amnesia | 1 | 2012 | 241 | 0.380 |
Why?
|
Rest | 1 | 2014 | 868 | 0.380 |
Why?
|
Female | 64 | 2022 | 375205 | 0.360 |
Why?
|
Reaction Time | 5 | 2019 | 2134 | 0.350 |
Why?
|
Space Perception | 1 | 2012 | 477 | 0.350 |
Why?
|
Pattern Recognition, Automated | 1 | 2015 | 1019 | 0.340 |
Why?
|
Diffusion Tensor Imaging | 5 | 2021 | 2169 | 0.330 |
Why?
|
Attention | 5 | 2019 | 2414 | 0.330 |
Why?
|
Longitudinal Studies | 15 | 2022 | 13536 | 0.330 |
Why?
|
Models, Neurological | 5 | 2021 | 1770 | 0.310 |
Why?
|
Presenilin-1 | 2 | 2022 | 645 | 0.310 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2641 | 0.300 |
Why?
|
Carbolines | 4 | 2020 | 249 | 0.280 |
Why?
|
Stress, Psychological | 1 | 2021 | 4176 | 0.280 |
Why?
|
Apolipoprotein E4 | 5 | 2020 | 611 | 0.270 |
Why?
|
Frontal Lobe | 3 | 2018 | 1414 | 0.270 |
Why?
|
Functional Laterality | 4 | 2018 | 2296 | 0.260 |
Why?
|
Software | 2 | 2015 | 4345 | 0.240 |
Why?
|
Atrophy | 6 | 2017 | 1509 | 0.240 |
Why?
|
Autopsy | 2 | 2022 | 990 | 0.220 |
Why?
|
Radiopharmaceuticals | 4 | 2020 | 2708 | 0.210 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2748 | 0.210 |
Why?
|
alpha-Amylases | 1 | 2020 | 38 | 0.210 |
Why?
|
Gyrus Cinguli | 2 | 2018 | 1070 | 0.200 |
Why?
|
Entorhinal Cortex | 2 | 2019 | 251 | 0.200 |
Why?
|
Dementia, Vascular | 1 | 2021 | 116 | 0.200 |
Why?
|
Extracellular Fluid | 1 | 2021 | 161 | 0.200 |
Why?
|
Widowhood | 1 | 2020 | 50 | 0.190 |
Why?
|
Amyloidogenic Proteins | 1 | 2020 | 91 | 0.190 |
Why?
|
Young Adult | 13 | 2020 | 55940 | 0.190 |
Why?
|
Acetylcholinesterase | 1 | 2019 | 157 | 0.190 |
Why?
|
Psychomotor Performance | 2 | 2018 | 1938 | 0.190 |
Why?
|
Linear Models | 4 | 2021 | 5986 | 0.190 |
Why?
|
Nerve Degeneration | 2 | 2021 | 790 | 0.180 |
Why?
|
Asymptomatic Diseases | 2 | 2019 | 577 | 0.180 |
Why?
|
Adult | 20 | 2022 | 211041 | 0.180 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2019 | 107 | 0.180 |
Why?
|
Substantia Nigra | 1 | 2020 | 358 | 0.180 |
Why?
|
Melanins | 1 | 2020 | 288 | 0.180 |
Why?
|
Activity Cycles | 1 | 2018 | 50 | 0.180 |
Why?
|
Acetates | 1 | 2019 | 307 | 0.170 |
Why?
|
Judgment | 1 | 2020 | 289 | 0.160 |
Why?
|
Loneliness | 1 | 2018 | 140 | 0.160 |
Why?
|
Social Participation | 1 | 2019 | 162 | 0.160 |
Why?
|
Sex Characteristics | 4 | 2022 | 2510 | 0.160 |
Why?
|
Early Diagnosis | 2 | 2012 | 1192 | 0.160 |
Why?
|
Cues | 2 | 2019 | 845 | 0.160 |
Why?
|
Plaque, Amyloid | 1 | 2020 | 673 | 0.150 |
Why?
|
Brain Stem | 1 | 2022 | 848 | 0.150 |
Why?
|
Choroid Plexus | 1 | 2018 | 191 | 0.150 |
Why?
|
Contrast Media | 5 | 2020 | 5267 | 0.140 |
Why?
|
Parkinson Disease | 2 | 2019 | 2578 | 0.140 |
Why?
|
Pilot Projects | 2 | 2021 | 7994 | 0.140 |
Why?
|
Sleep | 2 | 2022 | 4143 | 0.130 |
Why?
|
Gadolinium | 1 | 2019 | 910 | 0.130 |
Why?
|
Auditory Perception | 1 | 2018 | 516 | 0.130 |
Why?
|
Aniline Compounds | 4 | 2019 | 953 | 0.130 |
Why?
|
Cyclophosphamide | 1 | 2019 | 2189 | 0.120 |
Why?
|
Arousal | 1 | 2019 | 1138 | 0.120 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2013 | 105 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2019 | 1988 | 0.120 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2019 | 752 | 0.110 |
Why?
|
Heterozygote | 1 | 2019 | 2780 | 0.110 |
Why?
|
Hypertension | 1 | 2011 | 8161 | 0.110 |
Why?
|
Corpus Striatum | 1 | 2018 | 1252 | 0.110 |
Why?
|
Image Enhancement | 2 | 2020 | 2975 | 0.110 |
Why?
|
Severity of Illness Index | 4 | 2018 | 16008 | 0.110 |
Why?
|
Single-Blind Method | 1 | 2015 | 1588 | 0.100 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 934 | 0.100 |
Why?
|
Piperidines | 1 | 2019 | 1582 | 0.100 |
Why?
|
PubMed | 1 | 2011 | 118 | 0.100 |
Why?
|
Amyloidosis | 1 | 2018 | 788 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 2017 | 1508 | 0.100 |
Why?
|
Inflammation | 2 | 2022 | 10019 | 0.100 |
Why?
|
Imagination | 1 | 2012 | 222 | 0.100 |
Why?
|
Principal Component Analysis | 1 | 2014 | 962 | 0.100 |
Why?
|
Mental Status Schedule | 1 | 2011 | 313 | 0.100 |
Why?
|
Placebos | 1 | 2015 | 1733 | 0.100 |
Why?
|
Risk | 2 | 2019 | 9641 | 0.100 |
Why?
|
Computers | 1 | 2012 | 597 | 0.090 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2000 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2019 | 3179 | 0.090 |
Why?
|
Colombia | 2 | 2021 | 243 | 0.090 |
Why?
|
Anisotropy | 1 | 2012 | 1235 | 0.090 |
Why?
|
Heart Rate | 1 | 2020 | 4094 | 0.090 |
Why?
|
Ethylene Glycols | 2 | 2019 | 161 | 0.090 |
Why?
|
Thiazoles | 3 | 2019 | 1510 | 0.080 |
Why?
|
Radionuclide Imaging | 1 | 2011 | 2028 | 0.080 |
Why?
|
Biological Evolution | 1 | 2013 | 1084 | 0.080 |
Why?
|
Circadian Rhythm | 1 | 2018 | 2533 | 0.080 |
Why?
|
Brain Ischemia | 1 | 2020 | 3260 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15252 | 0.070 |
Why?
|
Causality | 1 | 2012 | 1137 | 0.070 |
Why?
|
Gadolinium DTPA | 2 | 2020 | 827 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2018 | 3418 | 0.060 |
Why?
|
Cohort Studies | 3 | 2021 | 39292 | 0.060 |
Why?
|
Time Factors | 3 | 2018 | 41038 | 0.060 |
Why?
|
ROC Curve | 1 | 2011 | 3518 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18712 | 0.060 |
Why?
|
African Americans | 1 | 2018 | 5118 | 0.060 |
Why?
|
Prognosis | 2 | 2021 | 28919 | 0.050 |
Why?
|
Phantoms, Imaging | 2 | 2020 | 2401 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2716 | 0.050 |
Why?
|
Capsaicin | 1 | 2021 | 235 | 0.050 |
Why?
|
Adolescent | 6 | 2019 | 84718 | 0.050 |
Why?
|
Spectrum Analysis | 1 | 2021 | 460 | 0.050 |
Why?
|
Animals | 3 | 2022 | 170486 | 0.050 |
Why?
|
Reflex | 1 | 2020 | 352 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2020 | 383 | 0.040 |
Why?
|
Exudates and Transudates | 1 | 2019 | 180 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 23020 | 0.040 |
Why?
|
Stroke | 1 | 2020 | 9256 | 0.040 |
Why?
|
Neurofibrillary Tangles | 1 | 2020 | 421 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7644 | 0.040 |
Why?
|
Physical Stimulation | 1 | 2019 | 542 | 0.040 |
Why?
|
Databases, Factual | 1 | 2013 | 7763 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 13314 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 29262 | 0.040 |
Why?
|
Fibrin | 1 | 2019 | 516 | 0.040 |
Why?
|
Cold Temperature | 1 | 2019 | 789 | 0.040 |
Why?
|
Semantics | 1 | 2019 | 595 | 0.040 |
Why?
|
Blood Pressure | 1 | 2011 | 8528 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2019 | 860 | 0.030 |
Why?
|
Melanocytes | 1 | 2018 | 521 | 0.030 |
Why?
|
Menopause | 1 | 2022 | 1518 | 0.030 |
Why?
|
Microvessels | 1 | 2019 | 565 | 0.030 |
Why?
|
Acoustic Stimulation | 1 | 2018 | 1191 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10566 | 0.030 |
Why?
|
Models, Biological | 1 | 2011 | 9907 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 69553 | 0.030 |
Why?
|
Diazepam Binding Inhibitor | 1 | 2013 | 4 | 0.030 |
Why?
|
Blood Proteins | 1 | 2019 | 1144 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1178 | 0.030 |
Why?
|
Amyloid | 1 | 2017 | 710 | 0.030 |
Why?
|
Mice | 1 | 2019 | 80876 | 0.030 |
Why?
|
Photic Stimulation | 1 | 2018 | 2021 | 0.030 |
Why?
|
Forecasting | 1 | 2020 | 2941 | 0.030 |
Why?
|
Prospective Studies | 3 | 2020 | 50597 | 0.030 |
Why?
|
Perception | 1 | 2017 | 1172 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1999 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2020 | 71483 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3397 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39038 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9402 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2017 | 6530 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2013 | 1123 | 0.020 |
Why?
|
Brain Concussion | 1 | 2018 | 1288 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4422 | 0.020 |
Why?
|
Life Style | 1 | 2018 | 3636 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8720 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6190 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 2518 | 0.020 |
Why?
|
Oxygen | 1 | 2017 | 4150 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12447 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2013 | 2040 | 0.020 |
Why?
|
Electroencephalography | 1 | 2019 | 5781 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2020 | 21194 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14836 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17218 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20308 | 0.010 |
Why?
|
Child | 1 | 2019 | 73636 | 0.010 |
Why?
|